Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus
March 22, 2016Aortic Waveform Analysis to Individualize Treatment in Heart Failure
February 3, 2017Leptin and Adiponectin as Predictors of Cardiovascular Risk After Gestational Diabetes Mellitus
A research team at University of Oslo led Tove Lekva investigated the association between gestational diabetes mellitus (GDM), cardiovascular risk, and plasma adiponectin, leptin, and the leptin/adiponectin (L/A) ratio in a group of 300 women during and after pregnancy. They discovered that a high L/A ratio during pregnancy, particularly in women with GDM, is linked to an unfavorable cardiovascular risk profile, suggesting that these biomarkers during pregnancy can predict future cardiovascular risk in this group.